KdT Ventures is on record against 19 companies.
This thesis focuses on writing first institutional checks ($500k–$5M) at the earliest stages for compute-applied chemistry and biology ventures, including therapeutics, industrial biotech, climate, and materials. It targets teams with advanced scientific degrees, with an implied global, non-region-specific geographic focus.